Skip to main content
. Author manuscript; available in PMC: 2012 Dec 7.
Published in final edited form as: J Clin Epidemiol. 2011 Dec;64(12):1412–1417. doi: 10.1016/j.jclinepi.2011.06.011

Table 1.

Projected 25-year NNS and additional NNT under different assumptions about the overdiagnosis rate among screen detections (O) and hazard ratios (H ) for disease-specific mortality associated with screening.

Projections in the absence of competing cause of death

Overdiagnosis
rate among screen
detections
Hazard ratio for
disease-specific
mortality associated
with screening
Incidence rate of
non-overdiagnosed
cancers in the
screened arm
Disease-specific
survival in screened
arm in the absence
of screening
Disease-specific
survival in screened
arm in the presence
of screening
Recipricol of
deaths prevented
by screening
(NNS)
Overdiagnoses relative
to deaths prevented by
screening
(additional NNT)
O H N = S(1−O) + C P = NR + (1 − N) PH 1/ (PHP) O×S / (PHP)

0.58 0.80 0.048 0.972 0.977 178.35 6.01
0.58 0.56 0.048 0.972 0.984 80.79 2.72
0.42 0.80 0.054 0.968 0.975 159.48 4.45
0.42 0.56 0.054 0.968 0.982 72.21 2.01
0.23 0.80 0.069 0.960 0.968 126.27 1.69
0.23 0.56 0.069 0.960 0.977 57.11 0.76
Projections in the presence of competing causes of death

Overdiagnosis rate
among screen
detections
Hazard ratio for
disease-specific
mortality associated
with screening
Cumulative incidence
of disease-specific
mortality in screened
arm
Cumulative incidence
of disease-specific
mortality in control arm
Recipricol of deaths
prevented by screening
(NNS)
Overdiagnoses relative to
deaths prevented by
screening
(additional NNT)

O H Ms Mc 1/(McMs) O×S/(McMs)

0.58 0.80 0.015 0.019 262.49 8.85
0.58 0.56 0.011 0.019 118.76 4.00
0.42 0.80 0.018 0.023 219.83 5.36
0.42 0.56 0.013 0.023 99.96 2.44
0.23 0.80 0.022 0.027 185.95 2.48
0.23 0.56 0.015 0.027 83.92 1.12